Ian Mongrain
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
-
- Blood groups and transfusion
Papers in
-
- Pharmacogenetics and Drug Metabolism 9
- Co-authors
- Marie‐Pierre Dubé (22 shared papers)Michael Phillips (7 shared papers)Sylvie Provost (14 shared papers)Alexandre Montpetit (1 shared paper)Réal Lemieux (1 shared paper)Maryse St‐Louis (1 shared paper)Jean‐Claude Tardif (11 shared papers)Yassamin Feroz Zada (8 shared papers)
- Journals
- Pharmacogenomics (5 papers)The Pharmacogenomics Journal (4 papers)Clinical and Translational Science (3 papers)Circulation Cardiovascular Genetics (2 papers)ESC Heart Failure (2 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Ian Mongrain
25 papers receiving 363 citations
Peers
Comparison fields: 5 of 66
- Pharmacology 58
- Hematology 47
- Transplantation 7
- Immunology 57
- Cardiology and Cardiovascular Medicine 52
Countries citing papers authored by Ian Mongrain
This map shows the geographic impact of Ian Mongrain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Mongrain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Mongrain more than expected).
Fields of papers citing papers by Ian Mongrain
This network shows the impact of papers produced by Ian Mongrain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Mongrain. The network helps show where Ian Mongrain may publish in the future.
Co-authors
The 25 scholars most cited alongside Ian Mongrain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 71 | |
| 2 | 2016 | 55 | |
| 3 | 2006 | 50 | |
| 4 | 2014 | 34 | |
| 5 | 2011 | 18 | |
| 6 | 2016 | 13 | |
| 7 | 2016 | 13 | |
| 8 | 2022 | 12 | |
| 9 | 2017 | 11 | |
| 10 | 2020 | 10 | |
| 11 | 2022 | 9 | |
| 12 | 2015 | 9 | |
| 13 | 2018 | 9 | |
| 14 | 2014 | 9 | |
| 15 | 2012 | 8 | |
| 16 | 2023 | 8 | |
| 17 | 2017 | 7 | |
| 18 | 2018 | 6 | |
| 19 | 2022 | 5 | |
| 20 | 2021 | 4 |
About Ian Mongrain
Ian Mongrain is a scholar working on Pharmacology, Molecular Biology, Oncology, Surgery and Cardiology and Cardiovascular Medicine, having authored 27 papers that have together received 369 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Genetic Associations and Epidemiology (3 papers), Gout, Hyperuricemia, Uric Acid (2 papers), Cancer, Lipids, and Metabolism (2 papers), Statistical Methods in Clinical Trials (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Pharmacology (58 citations), Hematology (47 citations), Transplantation (7 citations), Immunology (57 citations) and Cardiology and Cardiovascular Medicine (52 citations). Ian Mongrain has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Marie‐Pierre Dubé, Michael Phillips, Sylvie Provost, Alexandre Montpetit, Réal Lemieux, Maryse St‐Louis, Jean‐Claude Tardif, Yassamin Feroz Zada, Simon de Denus and Alessandro Sette. Their work appears in journals such as Pharmacogenomics, The Pharmacogenomics Journal, Clinical and Translational Science, Circulation Cardiovascular Genetics and ESC Heart Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.